NCT00037518View on ClinicalTrials.gov

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 30, 2001

Conditions
HyperparathyroidismParathyroid Neoplasms
Interventions
DRUG

AMG 073

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY